Kliinisen farmakologian yks.

Julkaisut 2003
Publications 2003

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aaltonen M et al. Asphyxia aggravates systemic hypotension but not pulmonary hypertension in piglets with meconium aspiration.
2 Anttila M et al. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects.
3 Frang H et al. Nonradioactive GTP binding assay to monitor activation of G protein-coupled receptors.
4 Ge H et al. Alpha2B-Adrenoceptor levels govern agonist and inverse agonist responses in PC12 cells.
5 Ge H et al. Constitutive precoupling to Gi and increased agonist potency in the alpha2B-adrenoceptor.
6 Hagelberg N et al. Altered dopamine D2 receptor binding in atypical facial pain.
7 Hagelberg N et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome.
8 Hallikainen T et al. Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking males.
9 Heikkinen T et al. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation.
10 Heikkinen T. Antidepressant drugs in pregnancy and lactation with special reference to citalopram and fluoxetine.
11 Heinonen P. A three amino acid deletion variant in the alpha2B-adrenergic receptor. Indentification and clinical association studies.
12 Helin-Salmivaara A et al. Focusing on changing clinical practice to enhance rational prescribing - collaboration and networking enable comprehensive approaches.
13 Helin-Salmivaara A et al. Heavy users of non-steroidal anti-inflammatory drugs: a nationwide prescription database study in Finland.
14 Helin-Salmivaara A et al. Keitä ovat tulehduskipulääkkeiden suurkäyttäjät?
15 Holmberg M. Neuroanatomical studies on alpha2-adrenoceptors. With special reference to the C-subtype in rat striatum and the central nervous system of alpha2C-adrenoceptor transgenic mice.
16 Holmberg M et al. Regional distribution of alpha2C-adrenoceptors in brain and spinal cord of control mice and transgenic mice overexpressing the alpha2C-subtype: an autoradiographic study with [3H]RX821002 and [3H]-rauwolscine.
17 Holopainen IE, Laurén HB. Neuronal activity regulates GABAA receptor subunit expression in organotypic hippocampal slice cultures.
18 Huupponen R et al. Lääkeinformaatiopalvelut lääkärin tukena.
19 Huupponen R et al. Pharmacokinetics of deramciclane, a novel anxiolytic agent, after intravenous and oral administration.
20 Härtter S et al. Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity.
21 Ingman K et al. Risperidone reduces limited access alcohol drinking in alcohol-preferring rats.
22 Ingman K et al. Selective delta-opioid receptor antagonist N,N(CH3)2-Dmt-Tic-OH does not reduce ethanol intake in alcohol-preferring AA rats.
23 Juhila J et al. The alpha2-adrenoceptor antagonist atipamezole reduces the development and expression of D-amphetamine-induced behavioural sensitization.
24 Jääskeläinen SK et al. Sevoflurane is epileptogenic in healthy subjects at surgical levels of anesthesia.
25 Kaisti KK et al. Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans.
26 Kallio J et al. Changes in diurnal sympathoadrenal balance and pitiutary hormone secretion in subjects with Leu7Pro polymorphismm in the prepro-neuropeptide Y.
27 Laakso A et al. Personality traits and striatal dopamine synthesis capacity in healthy subjects.
28 Laine K. Serotoniiniaineenvaihduntaan vaikuttavat masennuslääkkeet ja verenvuotoriski.
29 Laine K et al. Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone.
30 Laine K et al. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.
31 Laine K et al. A screening study on the liability of eight different female sex steroids to inhibit CYP2C9, 2C19 and 3A4 activities in human liver microsomes.
32 Laurén HB et al. Selective changes in gamma-aminobutyric acid type A receptor subunits in the hippocampus in spontaneously seizing rats with chronic temporal lobe epilepsy.
33 Lopez-Picon FR et al. Differential expression and localization of the phosphorylated and nonphosphorylated neurofilaments during the early postnatal development of rat hippocampus.
34 Lund V et al. Instantaneous beat-to-beat variability reflects vagal tone during hyperbaric hyperoxia.
35 Lähdesmäki J et al. Alpha2-adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the alpha2A-adrenoceptor subtype.
36 Lähdesmäki J et al. The alpha2A-adrenoceptor subtype is not involved in inflammatory hyperalgesia or morphine-induced antinociception.
37 Långsjö J et al. Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans.
38 Mustola ST et al. Electroencephalographic burst suppression versus loss of reflexes anesthesia with propofol or thiopental: Differences of variance ih the catecholamine and cardiovascular response to tracheal intubation.
39 Olli-Lähdesmäki T. Cellular Regulation of Human alpha2-Adrenoceptors. Studies on Receptor Targeting, Trafficking and Signalling.
40 Olli-Lähdesmäki T et al. Agonist-dependent trafficking of alpha2-adrenoceptor subtypes: dependence on receptor subtype and employed agonist.
41 Palovaara S. Effects of exogenous female sex steroids on selected cytochrome P450 enzyme activities.
42 Palovaara S et al. Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation.
43 Palovaara S et al. The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female sucjects.
44 Peltonen JM et al. Molecular mechanisms of ligand-receptor interactions in transmembrane domain V of the alpha2A-adrenoceptor.
45 Penttilä J et al. Effect of cardiac vagal outflow on complexity and fractal correlation properties of heart rate dynamics.
46 Sen S et al. Functional expression and direct visualization of the human alpha2B-adrenergic receptor and alpha2B-AR-green fluoroscent fusion protein in mammalian cell using Semliki Forest virus vectors.
47 Snapir A. Involvement of a genetic variation in the human alpha2B-adrenoceptor in acute coronary events and hypertension.
48 Snapir A et al. Effects of common polymorphisms in the alpha1A-, alpha2B, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline.
49 Snapir A et al. Variation in the alpha2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death.
50 Snapir A et al. The insertion/deletion variation in the alpha2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes.
51 Sundell J et al. High serum leptin is associated with attenuated coronary vasoreactivity.
52 Virtanen K. Insulin-stimulated glucose uptake in adipose tissue. Positron emission tomography studies in obesity and type 2 diabetes.
53 Virtanen KA et al. Differential effects of rosiglitazone and Metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.
54 Özdogan ÜK et al. Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice.
Julkaisutietokanta 29.9.2004 Publications Data Base 29.9.2004